FibroGen Announces $50 Million Royalty Monetization Financing with NovaQuest Capital Management
11.7.22
With its unique global platform, NovaQuest Capital Management promotes the late-stage development of life-saving drugs in order to reduce the cost of healthcare, address unmet medical needs, improve safety, and enhance overall quality of life.